The HSS Innovation Institute is singularly focused on advancing the field of musculoskeletal care by managing and commercializing the HSS portfolio of novel concepts and inventions. Our innovation team works closely with physicians, researchers, surgeons and scientists to support new, viable offerings that can improve clinical outcomes, enhance the patient experience or lower the cost of care delivery in a meaningful way. We are particularly focused on advancing early-stage innovations in the life sciences (novel biomedical products and platforms) as well as care delivery (digital health solutions and care delivery models).
What We Do
HSS has managed a pipeline of technology projects since 1979, and today, as the division charged with helping HSS inventions reach their full potential, the HSS Innovation Institute provides rigorous support throughout the entire innovation process. We offer dedicated project management, IP protection, a fair, systematic review process and connections to the right partners and investors. Drawing upon the vast network of resources available through HSS, the we develop, market, and license innovative technologies to companies, including HSS-created start-up companies, so that we can make these technologies widely available to the patients who need them.